Global Alternative Medicines Therapies Market to Witness Significant Revenue Growth Through 2020 – The Daily Chronicle

Posted on by

Alternative medicines and therapies refer to natural method of treatment which is different from conventional or pharmaceutical medicines. Alternative medical treatment includes non-mineral, non-vitamin and natural substances. On the basis of modality, alternative medicine market can be segmented into homeopathic medicine, herbal medicine, naturopathy, acupuncture, traditional Chinese medicine, ayurvedic medicine and others. Alternative therapies include magnetic therapy, herbal therapies, yoga, mud therapy and oil massage therapy, deep breathing exercise, osteopathic manipulation and meditation. Alternative medicines and therapies are used in chronic diseases, neurological diseases, reducing pain and depression and others.

To remain ahead of your competitors, request for a sample [emailprotected] https://www.persistencemarketresearch.com/samples/3190

Europe, followed by Asia and North America has the largest market for alternative medicines and therapies due rise in adoption of alternative medicines and natural therapies and technological advancement for drug development in this region. In addition, Japan is expected to show high growth rate in the alternative medicines and therapies market in next five years due to rise in aging population and high spending in alternative medicines and therapies in the region.

Increasing adoption of alternative medicines and natural therapies, technological advancement, rise in ageing population, ease to reach, increasing healthcare expenditure, government initiatives and rise in adoption of alternative medicines and therapies such as biosimilars are expected to drive the market for alternative medicines and therapies, In addition, increasing consumer spending in healthcare, rise in number of incidence of various diseases and cost effectiveness of alternative medicines and therapies are expected to drive the market for alternative medicines and therapies. However, economic downturn and side effects from the alternative medicines and strict rules and regulations led by some governments are restraining for the growth of global alternative medicines and therapies market.

To receive Methodology request here @ https://www.persistencemarketresearch.com/methodology/3190

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in alternative medicines and therapies market in Asia. In addition, rapid increase in aging population, increasing demand for herbal medicines and rise in demand of alternative drugs and natural therapies are expected to offer new opportunity to global alternative medicines and therapies market. However, safety in clinical trials and standardization is a challenge for the alternative medicines and therapies market. Increasing number of collaborations and partnerships and new products launched in the market are some of the trends have been observed in global alternative medicines and therapies market.

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/3190

Some of the major companies operating in the global alternative medicines and therapies market are

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi BirajdarPersistence Market ResearchAddress 305 Broadway, 7th Floor New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

More:

Global Alternative Medicines Therapies Market to Witness Significant Revenue Growth Through 2020 - The Daily Chronicle

Studying an alternative steroid treatment to calm cytokine storms in COVID-19 – The Mix

Posted on by

In a new trial funded through UABs urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.

Early results from the United Kingdom's RECOVERY trial this summer were a welcome piece of good news in the midst of the COVID-19 pandemic. Critically ill patients on ventilators who received dexamethasone, a corticosteroid drug, were at a one-third lower risk of dying than those who did not receive the drug. Patients receiving oxygen therapy, but not on ventilators, had a 20% lower risk of dying. Nature, the scientific journal, called it a"coronavirus breakthrough."

Better yet, as Nature noted, dexamethasone is both cheap and commonly used. The trouble is, "dexamethasone is already in short supply," said Randy Cron, M.D., Ph.D., professor of pediatrics and medicine at UAB. So Cron and Winn Chatham, M.D., professor of medicine at UAB, are conducting a pilot study of another corticosteroid, methylprednisolone. Outside of COVID-19, oncologists often use dexamethasone to treat hemophagocytic lymphohistiocytosis, a cytokine storm syndrome seen in patients with blood cancers such as leukemias and lymphomas. Rheumatologists such as Cron treat cytokine storm syndrome (where it is commonly called macrophage activation syndrome) in patients with lupus and rheumatoid arthritis using methylprednisolone.

"Methylprednisolone is more readily available than dexamethasone," Cron said. "The thought is if both are equally effective, then physicians can use what is available to them to treat COVID-19 cytokine storm syndrome." And, "by implication, other glucocorticoids will likely be equally effective at the glucocorticoid equivalent dosing."

UAB urgent research grants against COVID-19

This study is one of10 pilot projectsrecently funded by $402,000 in donations as part of the second round of UAB's urgent, high-impact COVID-19 grant initiative. This follows 14 projects funded in the first round of urgent, high-impact COVID-19 grants.

Cron is a leading expert on cytokine storm syndrome, a potentially life-threatening overreaction by inflammatory immune proteins known as cytokines. (In 2019, he published thefirst textbook on cytokine storm syndrome.) "Cytokines are there to fight off infections and ward off cancers," Cron said. "But when they are out of control, they can make you very ill."

Anyone battling a serious infection, regardless of cause, may experience a cytokine storm, Cron said. In addition to blood cancers and rheumatic diseases, cytokine storm syndrome is seen in herpes virus family member infections, and case reports have noted nearly 100 different infectious agents that can cause cytokine storms. In patients with COVID-19, clinicians increasingly see cytokine storm syndrome as a major factor in poor outcomes. Cytokine storm syndrome develops in a large percentage of COVID-19 patients who are ill enough to require hospitalization, Cron said.

Glucocorticoids, such as dexamethasone and methylprednisolone, are both "used to calm the cytokine storm," Cron said. "They have very broad-ranging effects on the immune system," including decreasing production of pro-inflammatory proteins and "decreasing function of multiple immune cell types."

In a pilot project that was one of10 recently fundedby UAB's urgent, high-impact COVID-19 grant initiative, Cron and Chatham, plan to enroll at least 30 patients hospitalized with COVID-19 pneumonia who have features of cytokine storm syndrome.

The World Health Organization initially recommended against use of glucocorticoids in treating COVID-19 because studies of their effectiveness when used against coronaviruses in SARS and MERS outbreaks had varying results, and glucocorticoids increase the risk of secondary infection in patients. "Nevertheless, out of desperation, many overwhelmed centers have resorted to glucocorticoids in treating COVID-19 cytokine storm syndrome," Cron and Chatham wrote in their project proposal, and early reports "have shown promising results." These drugs' effectiveness at calming cytokine storms means the benefits of short-term use outweigh concerns about secondary infections, Cron said. "They can be tapered over time to keep the cytokine storm syndrome under control while the patient improves clinically and by lab markers of disease," he said.

Patients in the study will be randomized to receive either 6mg daily of dexamethasone or 32mg daily of methylprednisolone. The goal is to reduce the need for invasive mechanical ventilation and ICU care. "We believe methylprednisolone will minimize ICU admissions and enhance survival," wrote Cron and Chatham in their project proposal.

Methylprednisolone and dexamethasone have similar side-effect profiles, "but are often used at different glucocorticoid equivalent dosing" methylprednisolone tends to be used at higher doses "and they have different pharmacokinetics, which has implications for tapering dosing when patients are recovering," Cron said.

Patients will receive the drugs at the doses listed above for seven days or until they show stable improvement in oxygen saturation and lower levels of markers of cytokine storm syndrome, including serum ferritin, D-dimer and C-reactive protein.

Genetic signatures for cytokine storm syndrome in COVID-19?

"Methylprednisolone is more readily available than dexamethasone. The thought is if both are equally effective, then physicians can use what is available to them to treat COVID-19 cytokine storm syndrome. And, by implication, other glucocorticoids will likely be equally effective at the glucocorticoid equivalent dosing."

The researchers also plan to explore genetic risk factors that may be shared by COVID-19 patients who develop cytokine storm syndrome. Cron and colleagues have identified genetic risk factors in other cytokine storm syndromes, including thosetriggered by H1N1 influenza. This earlier work suggests that as much as 15% of the general population carries genetic mutations putting them at higher risk for developing cytokine storm syndrome. Finding such risk factors in COVID-19 patients would allow clinicians to target treatments to patients with the highest potential for success on those therapies.

Cron and Chatham are co-principal investigators on the methylprednisolone study, which also includes Devin Absher, Ph.D., of the HudsonAlpha Institute of Biotechnology, where whole genome-sequencing of patients will be done.

See the rest here:

Studying an alternative steroid treatment to calm cytokine storms in COVID-19 - The Mix

Alternative Therapies Market to Witness Huge Growth by 2025 | Nordic Naturals, Helio USA, Yoga Tree – The PRNews Pulse

Posted on by

HTF Market Intelligence added research publication document on COVID-19 Outbreak-Global Alternative Therapies Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of COVID-19 Outbreak- Alternative Therapies market. The study provides valuable market size data for historical (Volume** & Value) from 2014 to 2018 which is estimated and forecasted till 2026*. Some are the key & emerging players that are part of coverage and have being profiled are Iyengar Yoga Institute, Pure encapsulations, Inc., Herbal Hills, The Healing Company, Quantum Touch Inc., Nordic Naturals, Helio USA Inc., Yoga Tree, Deepure Plus, Herb Pharm, John Schumacher?s Unity Woods Yoga Center & Columbia Nutritional Inc..

Click to get COVID-19 Outbreak-Global Alternative Therapies Market Research Sample PDF Copy Now

1. External Factor Analysis

An external analysis looks at the wider business environment that affects the business. This industry assessment covers all the factors that are outside the control. It includes both the micro and macro environmental factors.

MACRO ENVIRONMENT: In-depth coverage on Factors such governmental laws, social construct and cultural norms, environmental conditions, economic, and technology.

MICRO ENVIRONMENT: Factors highlighting the rivalry of the competition.

2. Growth & Margins

Players that are having stellar growth track record is a must see view in the study that Analyst have covered. From 2014 to 2019, some of the company have shown enormous sales figures, with net income going doubled in that period with operating as well as gross margins constantly expanding. The rise of gross margins over past few years directs strong pricing power of the competitive companies in the industry for its products or offering, over and above the increase in the cost of goods sold.

Check for more detail, Enquire about Latest Edition with COVID Impact Analysis @ https://www.htfmarketreport.com/enquiry-before-buy/2810004-covid-19-outbreak-global-alternative-therapies-industry-market

3. Ambitious growth plans & rising competition?

Industry players are planning to introduce new products launch into various markets around the globe considering applications / end use such as Direct Contact, E-training & Distance Correspondence. Examining some latest innovative products that are vital and may be introduced in EMEA markets in last quarter 2019 and 2020. Considering all round development activities of Iyengar Yoga Institute, Pure encapsulations, Inc., Herbal Hills, The Healing Company, Quantum Touch Inc., Nordic Naturals, Helio USA Inc., Yoga Tree, Deepure Plus, Herb Pharm, John Schumacher?s Unity Woods Yoga Center & Columbia Nutritional Inc., some players profiles are worth attention seeking.

4. Where the COVID-19 Outbreak- Alternative Therapies Industry is today

Though latest year might not be that encouraging as market segments especially , Traditional Alternative Medicine, Body, Diet and Herbs, External Energy, Mind & Senses have shown modest gains, growth scenario could have been changed if Iyengar Yoga Institute, Pure encapsulations, Inc., Herbal Hills, The Healing Company, Quantum Touch Inc., Nordic Naturals, Helio USA Inc., Yoga Tree, Deepure Plus, Herb Pharm, John Schumacher?s Unity Woods Yoga Center & Columbia Nutritional Inc. would have plan ambitious move earlier. Unlike past, but decent valuation and emerging investment cycle to progress in the North America (Covered in Chapter 7 and 14), United States, Canada, Mexico, Europe (Covered in Chapter 8 and 14), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 9 and 14), China, Japan, South Korea, Australia, India, Southeast Asia, Others, Middle East and Africa (Covered in Chapter 10 and 14), Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others, South America (Covered in Chapter 11 and 14), Brazil, Argentina, Columbia, Chile & Others., many growth opportunities ahead for the companies in 2020, it looks descent today but stronger returns would be expected beyond.

Buy full version of this research study @ https://www.htfmarketreport.com/buy-now?format=1&report=2810004

Insights that Study is offering : Market Revenue splits by most promising business segments. [By Type (, Traditional Alternative Medicine, Body, Diet and Herbs, External Energy, Mind & Senses), By Application (Direct Contact, E-training & Distance Correspondence) and any other business Segment if applicable within scope of report] Market Share & Sales Revenue by Key Players & Local Emerging Regional Players. [Some of the players covered in the study are Iyengar Yoga Institute, Pure encapsulations, Inc., Herbal Hills, The Healing Company, Quantum Touch Inc., Nordic Naturals, Helio USA Inc., Yoga Tree, Deepure Plus, Herb Pharm, John Schumacher?s Unity Woods Yoga Center & Columbia Nutritional Inc.] A separate section on Entropy to gain useful insights on leaders aggressiveness towards market [Merger & Acquisition / Recent Investment and Key Development Activity Including seed funding] Competitive Analysis: Company profile of listed players with separate SWOT Analysis, Overview, Product/Services Specification, Headquarter, Downstream Buyers and Upstream Suppliers. Gap Analysis by Region. Country break-up will help you dig out Trends and opportunity lying in specific territory of your business interest.

Read Detailed Index of full Research Study at @ https://www.htfmarketreport.com/reports/2810004-covid-19-outbreak-global-alternative-therapies-industry-market

Thanks for showing your interest; you can also get individual chapter wise section or region wise report version like ASEAN, GCC, LATAM, Western / Eastern Europe or Southeast Asia.

About Author:

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]

Connect with us at LinkedIn | Facebook | Twitter

Originally posted here:

Alternative Therapies Market to Witness Huge Growth by 2025 | Nordic Naturals, Helio USA, Yoga Tree - The PRNews Pulse

Privacy-focused browsers return more health misinformation, researchers claim – NS Tech

Posted on by

A new study overseen by the Oxford Internet Institute (OII) claims that privacy-preserving browsers such as DuckDuckGo return more health misinformation such as anti-vaccine sites than Google.

The study, published in Frontiers in Medicine, analysed the first 30 webpages returned for the search term vaccines autism, to gauge the volume of anti-vax information that came up. It found that alternative search engines (Duckduckgo, Ecosia, Qwant, Swisscows, and Mojeek) and other commercial engines (Bing, Yahoo) returned between 10-53 per cent anti-vaccine pages, while Google returned 0 per cent.

Google has attracted growing criticism in recent years over the vast amount of personal data it hoovers up. This has led to privacy-focused rivals such as DuckDuckGo popping up, which have gained a vocal support base in a short period of time.

DuckDuckGo expressly avoids personalising users search results to negate the filter bubble effect. It collates search results from more than 400 sources, but none from Google. Its website indicates that traffic has continually risen from its inception in 2013 reaching more than 55 million searches in a day this month. However, Google still massively dominates accounting for more than 90 per cent of the search market.

The authors of the study, which was overseen by the OIIs Professor Luciano Floridi and included contributions from research students across Europe, argue that their findings indicate a trade-off between a browsers privacy and information quality. But its not clear whether different approaches to privacy actually explains the differences in the respective browsers search results.

Googles search results are determined by a number of different algorithms that take into account various factors including words of your query, relevance and usability of pages, expertise of sources and your location and settings, according to its site.

Read next: Were tackling social media disinformation all wrong heres how to fix it

Google proactively rates and ranks pages based on quality. In a Google document that provides guidelines to its search quality evaluators, it says that pages that potentially spread hate, cause harm, or misinform or deceive users, should receive the Lowest rating. This can include content such as demonstrably inaccurate content or debunked or unsubstantiated conspiracy theories.

Googles algorithmic tweaks are notorious among websites for resulting in sudden dips in traffic. There have even been allegations that Google maintains a blacklist of both right-wing and left-wing sites, but this has been denied by the company.

The new research was carried out as part of student projects and wasnt explicitly funded, although the OII has received funding from Google for other work this year. In March 2019, Floridi was also appointed to Googles short-lived Advanced Technology External Advisory Council, having previously advised it on the right to be forgotten. In 2015, he was described as the companys in-house philosopher.

The report argues that the greater volume of anti-vax content turned up by other search engines is an indictment of their search algorithms, and that mechanisms should be developed to test search engines from the perspective of information quality [] before they can be deemed trustworthy providers of public health information.

Read next: How did 5G conspiracy theorists become arsonists?

However, this betrays a somewhat twisted understanding of search engines, given that they are not considered trusted providers of information neither legally nor in terms of user expectations. (The raft of illegal and otherwise vile or offensive content hosted on internet search engines, means that if they were liable for the content that appeared on them, theyd all be shut down tomorrow.) The purpose of search engines is to index content on the internet. They perform the role of displaying and, to different degrees, curating, the available content on the web.

The World Health Organisation lists vaccine hesitancy as one of the top 10 threats to global health in 2019. However, its not clear that attempting to expunge or hide anti-vax information from the web would affect these attitudes. Its extremely hard to separate out the effect of online misinformation on behaviour primarily because people come into contact with a range of external stimuli all of which have an incremental effects on their eventual beliefs and actions.

Covid-19 has provided a useful test case for examining this hypothesis, and so far evidence that online misinformation has a serious and widespread effect on health outcomes is not conclusive. For example, a recent study published in the American Journal of Tropical Medicine and Hygiene mentioned that online Covid-19 misinformation was linked to thousands of deaths, but the sources it referred to all concerned people in Iran drinking ethanol in the misguided belief that it would cure the virus.

Iran is very different to countries in the west in terms of both its internet ecosystem, which is subject to a high degree of censorship, and health education. A World Health Organisation study published in 2019 found that 46 per cent of Iranian adults had inadequate health literacy. A BBC article notes that the number of deaths in Iran attributed to Covid-19 misinformation is itself uncertain because alcohol is banned in the country and the bootleg moonshine is often contaminated.

Floridis study itself didnt investigate material harms that have resulted primarily because of online misinformation, but it does highlight a couple of examples. It mentions a case in China where a cancer patient died by following an alternative therapy that they discovered online. The report notes that in response, Chinese authorities issued new rules that require search engines to provide objective, fair, and authoritative results appearing somewhat strangely to endorse the countrys censorious approach to the web.

However, most of the scare-mongering about the impact on fake news or misinformation on health behaviours is based on anecdotal and one-off cases, as opposed to rigorous academic research. In fact, a working paper by Ciara M. Greene and Gillian Murphy of Irelands University College Dublin and University College Cork, found that casual exposure to a fake news story was unlikely to have significant effects on future behaviour, concluding that at present, there is no empirical data that supports the assumption that fake news has a grave impact on health.

Greene told the Nieman Lab that the authors suspect that real-world behavioural effects will mostly emerge in contexts where individuals seek out many stories all advocating the same position, and which are congenial to the individuals existing views; anti-vax or climate change denial networks would be a good example of this.

Read next: Does Americas clean network initiative mean the end of the open web?

Indeed, studies indicate that people who hold anti-vaccination beliefs are very likely to be plugged into a conspiratorial worldview that dictates the populace is being lied to by mainstream politicians, institutions and media. A 2016 study (PDF) found that new adoptees are already predisposed to the beliefs through government distrust and general paranoia.

As such, theres not much good evidence that hiding or removing misinformation from the internet actually dampens beliefs. In some cases, removing or demoting this kind of content can even feed into this paranoid worldview, where the individual believes that companies such as Google are colluding with the government to restrict certain information not because its bogus, but because its dangerously true.

Studies have found that those with less education (as well as older and more conservative people) are more likely to share misinformation. But many factors can come into play. A 2015 study published in Plos One, found that educational level and thinking style did not predict vaccination rejection, but psychosocial factors such as preferring alternative medicine and the endorsement of spirituality as a source of knowledge did lead to vaccine-negative attitudes.

The OII study argues that this presents a double jeopardy, in that those who hold anti-authoritarian views and an interest in alternative medicine are more likely to use alternative search providers because of privacy concerns. The report argues that therefore, while the alternative providers might reach a proportionally smaller audience they are reaching an audience that is already more receptive to anti-vaccine information and therefore more vulnerable to its effects.

However, these are also the very people likely to be more predisposed to believe that demoting search results is a result of the information being true. An emphasis on education and digital literacy might equip people to better deal with misinformation, as opposed to demoting search results. Even better, an analysis of why people are prone to mistrust of governments and experts could inform a more successful means of intervention.

DuckDuckGo didnt respond to a request for comment.

Continued here:

Privacy-focused browsers return more health misinformation, researchers claim - NS Tech

1933 Industries Appoints Mr. Paul Rosen to its Board of Directors – PRNewswire

Posted on by

VANCOUVER, BC, Sept. 2, 2020 /PRNewswire/ - 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company with a diverse portfolio of consumer-driven brands, is pleased to announce that its Chief Executive Officer, Mr. Paul Rosen, has been appointed to the Board of Directors.

Mr. Rosen has been involved with 1933 Industries in the capacities of strategic investor, advisor and most recently, as CEO of the Company, instituting a high level of stewardship and financial oversight that is guiding the Company into its next phase of development. Leveraging his extensive experience in the cannabis industry as one of its earliest and most active entrepreneurs and company builders, Mr. Rosen brings vast corporate governance expertise to his new board position, having co-founded and served as President and CEO of PharmaCan Capital Corp., later corporate rebranded to The Cronos Group (NASDAQ: CRON; TSX: CRON); as founder and former CEO and Chairman of Tidal Royalty Corporation; as a previous board member and Audit Committee Chair of iAnthus Capital Holdings (IAN.CN); and as a previous board member of Hill Street Beverages (BEER.VN) and High Tide Ventures (HITI.CN).

Currently, Mr. Rosen is the Executive Chairman of Global Go, a consultancy focused on the global regulated cannabis industry and is a co-founder and Chairman of Pantry Co., a cannabis focused start up in the functional food market. Mr. Rosen is a member of the Law Society of Ontario, and previously practiced constitutional law.

"My appointment as CEO has helped accelerate positive change at 1933 Industries. Working closely alongside Eugene Ruiz, President of the Company, we are steering the business at a critical junction, instituting prudent financial controls, reigning in spending and shoring up the balance sheet", said Mr. Rosen. "During the last two months, we have shifted our strategy, focussing on our core market in Nevada and on our best-in-class cultivation infrastructure, making meaningful improvements that are already being realized. As a member of the Board of Directors, I will have the opportunity to further assist in strengthening the Company's performance, while continuing to demonstrate my long-term commitment to the success of 1933 Industries as we grow our business into a profitable and respected entity."

About 1933 Industries Inc.1933 Industries is a vertically-integrated, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing, and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG LLC.

About Alternative Medicine AssociationAMA is a licensed medical and adult-use cannabis cultivation and extraction subsidiary that produces its own branded line of unique cannabis-based products and manufactures third-party brands.With state-of-the-art cultivation and extraction facilities based in Las Vegas, Nevada, AMA seeks to offer medical patients and recreational users alike a cannabis experience that's exceptional, potent, and consistent in quality. Our house brands include: AMA Flower and Pre-Rolls, Distillate and Concentrates. Partners under licensing agreements include: Blonde Cannabis, Bloom, Five Star Extracts, The Pantry Company, PLUGplay, and The Original Jack Herer.

About Canna Hemp With an extensive product line that includes topicals, creams, vapes, elixirs, capsules, dabs, lip balms and pre and post workout recovery sports products, 1933 Industries' proprietary Canna Hemp brand utilizes the power of hemp and CBD to bring natural wellness. The Company's flagship products, the Canna Hemp Relief Cream and Canna Hemp X Recovery Cream are recognized as best topicals in the market. Canna Hemp X is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance. All products are triple and third-party tested for safety with test results imbedded via QR codes for traceability.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on http://www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE 1933 Industries Inc.

https://1933industries.com/

Follow this link:

1933 Industries Appoints Mr. Paul Rosen to its Board of Directors - PRNewswire

Impact Of Covid-19 on Alternative Therapies Market By Top Key Players Helio USA Inc., Herb Pharm, Yoga Tree, Quantum Touch Inc. – The PRNews Pulse

Posted on by

Contrive Datum Insights has published a newly innovative statistical data, titled as Alternative Therapies Market. It is a valuable source of statistical data for Alternative Therapies market and includes accurate information, which uses primary and secondary research techniques. The research analyst provides comprehensive data, which enhances the growth of the industries. This report focuses on the basic requirement strategies of the businesses, which helps to enlarge the productivity. Additionally, it offers different market segments, such as application, types, size, end users, cost etc.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @: https://www.contrivedatuminsights.com/request-sample/65842

It includes the research studies about the current trends in different sectors on the basis of their scope. The analyst of this report focuses on the static and dynamic pillars of the industries, for basic understanding of the strategies. In addition to this, it identifies the drivers and opportunities for the development of the businesses. Additionally, it focuses on restraints to analyze the issues from the existing business strategies. It focuses on the various aspects, such as application areas, platforms, and leading players operating across the globe.

Major Companies Profiled in this Report Includes: Helio USA Inc., Herb Pharm, Yoga Tree, Quantum Touch Inc., Herbal Hills, The Healing Company, John Schumachers Unity Woods Yoga Center, Pure encapsulations, Inc., Deepure Plus, Nordic Naturals, Columbia Nutritional Inc., Iyengar Yoga Institute

This statistical report is the comprehensive analysis of different barriers of Alternative Therapies market. The detailed description of the historical data, current scenario and future predictions have been provided in the report. It gives accurate data of leading companies, which promotes the insights, to make great decisions in the businesses. In this report, you will also find additional data about the economics of the Alternative Therapies market.

Global Alternative Therapies Market Segmentation:

On the Basis of Type: Traditional Alternative Medicine, Body, Diet and Herbs, External Energy, Mind, Senses

On the Basis of Application: Direct Contact, E-training, Distance Correspondence

On the Basis of Application: Direct Contact, E-training, Distance Correspondence

Regions Covered in the Global Alternative Therapies Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The global regions such as, North America, Latin America, Europe, Japan, and India are considered on the basis of the manufacturing, productivity, size, and revenue. This report is summarized with the competitive landscape along with the recent developments in Alternative Therapies Market sectors for growth of the businesses.

Hurry Up! Get Up to 20% Discount on this [emailprotected]: https://www.contrivedatuminsights.com/request-discount/65842

The reports conclusion leads into the overall scope of the global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the global Alternative Therapies market in the near future. The report will assist understand the requirements of customers, discover problem areas and possibility to get higher, and help in the basic leadership manner of any organization. It can guarantee the success of your promoting attempt, enables to reveal the clients competition empowering them to be one level ahead and restriction losses.

Global market research objectives:

Major questions addressed through this global research report:

Table of Content (TOC):

Chapter 1 Introduction and Overview

Chapter 2 Industry Cost Structure and Economic Impact

Chapter 3 Rising Trends and New Technologies with Major key players

Chapter 4 Global Alternative Therapies Market Analysis, Trends, Growth Factor

Chapter 5 Alternative Therapies Market Application and Business with Potential Analysis

Chapter 6 Global Alternative Therapies Market Segment, Type, Application

Chapter 7 Global Alternative Therapies Market Analysis (by Application, Type, End User)

Chapter 8 Major Key Vendors Analysis of Alternative Therapies Market

Chapter 9 Development Trend of Analysis

Chapter 10 Conclusion

Place a Direct Order Of this Report: https://www.contrivedatuminsights.com/buy/65842

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Any special requirements about this report, please let us know and we can provide custom report.

We are always happy to assist you on your queries: [emailprotected]Phone No:+19084598372Contrive Datum Insights: http://www.contrivedatuminsights.com/

Read this article:

Impact Of Covid-19 on Alternative Therapies Market By Top Key Players Helio USA Inc., Herb Pharm, Yoga Tree, Quantum Touch Inc. - The PRNews Pulse

Nanomedicine Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast To 2026 |…

Posted on by

Nanomedicine Market

DataIntelo, 03092020: The research report on the Nanomedicine Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.

Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied systematically, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report.

Get a PDF Copy of the Sample Report for Free @ https://dataintelo.com/request-sample/?reportId=81345

The Major Manufacturers Covered in this Report:CombimatrixAblynxAbraxis BioscienceCelgeneMallinckrodtArrowhead ResearchGE HealthcareMerckPfizerNanosphereEpeius BiotechnologiesCytimmune SciencesNanospectra Biosciences

The Research Study Focuses on:

By Types:Quantum dotsNanoparticlesNanoshellsNanotubesNanodevices

By Applications:Segmentation encompasses oncologyInfectious diseasesCardiologyOrthopedicsOthers

By Regions:

To get this report at incredible Discounts, visit @ https://dataintelo.com/ask-for-discount/?reportId=81345

The Nanomedicine Market Report Consists of the Following Points:

Make an Inquiry of the Nanomedicine Market Report @ https://dataintelo.com/enquiry-before-buying/?reportId=81345

In conclusion, the Nanomedicine Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rate, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info:Name: Alex MathewsAddress: 500 East E Street, Ontario,CA 91764, United States.Phone No: USA: +1 909 545 6473 | IND: +91-7000061386Email: [emailprotected]Website: https://dataintelo.com

Follow this link:

Nanomedicine Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast To 2026 |...

Nanomedicine Market Segmentation By Qualitative And Quantitative Research Incorporating Impact Of Economic And Non-Economic Aspects By 2027 – Reports…

Posted on by

The report on the Global Nanomedicine Market provides a panoramic view of the current developments and progresses within the Nanomedicine market. The report further analyzes the impact of the novel COVID-19 pandemic on the Nanomedicine market and provides an accurate insight into the current and future market fluctuations. Factors likely to influence the growth of the market, current trends, opportunities, restraining factors, and business landscape are discussed in-depth in the market study.

The Nanomedicine market report further discusses the definitions, classifications, types, applications, market overview, manufacturing processes and costing, raw materials, among other key points. The report additionally provides SWOT analysis, investment feasibility, and investment return analysis.

Get a sample copy of the Nanomedicine market report @ https://www.reportsanddata.com/sample-enquiry-form/1048

The major players profiled in the global Nanomedicine market report include:

Arrowhead Pharmaceuticals Inc. AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation, and Johnson & Johnson.

Market Segment by Regions:

Product Outlook (Revenue, USD Billion; 2017-2027)

Drug Delivery System Outlook (Revenue, USD Billion; 2017-2027)

Application Outlook (Revenue, USD Billion; 2017-2027)

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1048

Key Questions Answered in the Report:

Key takeaways from the Nanomedicine market report:

To read more about the Global Nanomedicine Market @ https://www.reportsanddata.com/report-detail/nanomedicine-market

Thank you for reading our report. For more information on customization, please reach out to us. Our team will ensure the report is tailored according to your needs.

Original post:

Nanomedicine Market Segmentation By Qualitative And Quantitative Research Incorporating Impact Of Economic And Non-Economic Aspects By 2027 - Reports...

NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference -…

Posted on by

SHELTON, CT / ACCESSWIRE / September 4, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today reported on the Presentation by Anil R. Diwan, Ph.D., its President and Executive Chairman, at the LD 500 investor conference yesterday, Thursday, September 3rd at 11:20 AM EDT.

Dr. Diwan presented the Company's rapid progress in developing a drug to attack the SARS-CoV-2 virus that causes COVID-19 spectrum of diseases.

He summarized the Company's progress since embarking into this endeavor with very limited resources since about January, 2020, and boot-strapping on its past work against coronaviruses. Dr. Diwan stated that the Company is close to declaring a clinical candidate for treating patients infected with SARS-CoV-2. The Company has previously reported that its development candidates have shown to be effective against multiple coronaviruses in the Company's own BSL2 Virology Lab, and have also shown to be highly effective in an animal study to combat infection by a related coronavirus that uses the same ACE2 receptor as does SARS-CoV-2.

Dr. Diwan stated that this broad-spectrum effectiveness against coronaviruses provides scientific reasoning that even as a field coronavirus strain mutates, our drug candidates would continue to remain effective, unlike antibodies and vaccines.

In addition, our current development candidates against COVID-19 have also been shown to be extremely safe in animal studies. Their effectiveness in cell culture and animal models has led us to believe that they are worthy of human clinical development.

Subsequently, the Company has completed CMC ("Chemistry, Manufacture, and Controls") studies that would be required for an IND ("Investigational New Drug) application to the U.S. FDA. The Company is also in the process of drafting sections of an IND for COVID-19 drug candidate. The Company is currently conducting studies to finalize its clinical candidate.

Dr. Diwan further stated the Company's intent of developing an integrated approach to combat SARS-CoV-2 that could potentially result in a cure for the virus. The virus lifecycle is a convolution of two parts: (a) re-infection of a host cell by external virus (after primary infection from outside the host body), and (b) replication (i.e. production of new virus particles) in infected cells and egress of the newly produced virus particles to feed back into the (a) re-infection cycle, completing the loop.

Dr. Diwan explained that if both parts of the virus lifecycle are blocked, then a virus infection would be cured, except in the case of latent viruses.

A nanoviricide® is uniquely capable of accomplishing this task of integrated attack against both the re-infection and replication mechanisms, as the Company has previously stated. The nanoviricide is already designed to block the re-infection cycle part. In addition, it can carry in its "belly", a payload that can block the replication cycle part.

NanoViricides has accelerated its anti-coronavirus program to develop a "second generation" nanoviricide against coronaviruses that is designed to block both re-infection and replication cycles, in addition to the current development of the "first generation" anti-coronavirus drug intended to block the re-infection cycle part. The Company accelerated these efforts due to both the severity of the pandemic, and the difficulty of curing the SARS-CoV-2 infection as exemplified by several recent unsuccessful or partially successful clinical studies.

In particular, the Company has successfully encapsulated remdesivir inside its current development drug candidates. The resulting drug, which is expected to be superior to remdesivir alone, as well as many other drugs, is already in pre-clinical testing, Dr. Diwan disclosed.

Remdesivir inhibits replication cycle by blocking the RNA polymerase activity essential for virus genome duplication. It is highly effective in cell culture studies against many viruses. However, its success in reducing viral load and pathology has been limited in human clinical studies. This is probably substantially due to the extensive metabolism that the drug is subjected to as soon as it enters the bloodstream.

Encapsulation into a nanoviricide is anticipated to protect remdesivir from this extensive metabolism and thus improve its clinical effect profile. Additionally, the nanoviricide itself is expected to block the re-infection cycle part of the virus lifecycle. Thus the Company believes that this novel integrated nanomedicine approach could produce a highly effective drug against coronaviruses, and against SARS-CoV-2 in particular, possibly on the way to a cure.

The Company develops its class of drugs, that we call nanoviricides®, using a platform technology. This approach enables rapid development of new drugs against a number of different viruses. A nanoviricide is a "biomimetic" - it is designed to "look like" the cell surface to the virus. The nanoviricide® technology enables direct attacks at multiple points on a virus particle. It is believed that such attacks would lead to the virus particle becoming ineffective at infecting cells. Antibodies in contrast attack a virus particle at only a maximum of two attachment points per antibody.

Because of the worldwide urgency of the pandemic caused by the SARS-CoV-2 virus, we have focused all our efforts recently on taking a drug against SARS-CoV-2 into human clinical trials for treatment of patients with COVID-19. An effective drug could potentially allow full-fledged opening of normal activities, including schools, businesses, and economies all over the world.

Soon after it files an IND for a COVID-19 drug candidate, the Company intends to re-engage its NV-HHV-101 shingles drug candidate clinical trials program towards IND filing. The Company has put the shingles program on hold due to perceived difficulties in conducting proposed shingles clinical trials during the COVID-19 pandemic. The Company is near finalizing the selection of clinical trial sites and finalizing clinical trial protocols for the shingles IND filing.

The NV-HHV-101 drug candidate is expected to open up a billion dollar market for the shingles treatment space, and also lead to further development of drugs against other herpesviruses such as HSV-1 that causes "cold sores" and HSV-2 that causes genital herpes. The multiple indications enabled by the HerpeCide program drug candidates may potentially address a several billion dollar marketspace.

For additional information about NanoViricides, please visit the company's website at http://www.nanoviricides.com .

About NanoViricides NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. The Company is in the process of completing an IND application to the US FDA for this drug candidate. The Company cannot project an exact date for filing an IND because of its dependence on a number of external collaborators and consultants, the effects of recent COVID-19 restrictions, and re-prioritization for COVID-19 drug development work.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides' platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus and Ebola/Marburg viruses. The Company has executed a Memorandum of Understanding with TheraCour that provides a limited license for research and development for drugs against human coronaviruses. The Company intends to obtain a full license and has begun the process for the same. The Company's technology is based on broad, exclusive, sub-licensable, field licenses to drugs developed in these areas from TheraCour Pharma, Inc. The Company's business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products. FDA refers to US Food and Drug Administration. IND application refers to "Investigational New Drug" application. CMC refers to "Chemistry, Manufacture, and Controls".

Contact: NanoViricides, Inc. info@nanoviricides.com

Public Relations Contact: MJ Clyburn TraDigital IR clyburn@tradigitalir.com

SOURCE: NanoViricides, Inc.

View source version on accesswire.com: https://www.accesswire.com/604794/NanoViricides-is-Developing-Drugs-Against-SARS-CoV-2-with-an-Integrated-Approach-to-Combat-COVID-19-as-Reported-at-The-LD-500-Virtual-Conference

Originally posted here:

NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference -...

Impressive Trends and Future Scope of Nanocapsules Market – StartupNG

Posted on by

Nanopharmacology is a new branch of pharmacology which deals with the application of nanotechnology in the field of nanomedicine. This is a potential step towards curing and prevention of disease by using molecular knowledge about human body and molecular tools. Nanopharmacology studies the interaction between nanoscale drugs and proteins such as DNA, RNA and cells & tissues. It also studies the interaction between physiological systems and traditional drugs at nanoscale level.

View Report : https://www.transparencymarketresearch.com/nanocapsules-market.html

Nanoparticles are solid colloidal particles that include both nanospheres and nanocapsules. Nanocapsule is any nanoparticles that consist of a shell and a space in which desired substances may be placed. It is made up of a nontoxic polymer. They are also known to be drug delivery agents in the size range of 10-1000 nm. These capsules are made up of molecules called as phospholipids such as liposomes. Now-a-days many other materials such as variety of polymers have been used to make nanocapsules by self assembly process. Polymeric capsules are studied extensively as particulate carriers in the medical and pharmaceutical fields as they act as good drug delivery systems as a result of their sustained and control release property and subcellular size.

The ultrafine size of nanocapsules itself is one of the useful function as the finer drug are suitable to be absorbed easily through biological systems. The special features and functions of nanoparticles include slow release: the capsules releases drugs molecules slower over a long period of time, quick release: the capsule shell breaks and comes in contact with a surface, specific release: the shell is designed to break open when a molecule receptor binds to a specific chemical and moisture release: the shell breaks down and releases drug in the presence of water among other features. The state of the art nanocapsulation medications include drugs deliver to specific locations within the body, cuts down on the amount of drug per dose and reduces the risk of side effects. The only limitation is that it is designed to target pre-determined areas.

Get Brochure of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5321

Cancer, neutraceuticals, ethyl alcohol absorption, food usage and self healing materials are the major applications of nanocapsules. Water soluble polymer shells are manufactured to deliver a protein known as apoptin into cancer cells. Neutraceuticals are substances which are placed into food to enhance nutrition. The smaller the nanocarrier, the better the delivery particles and solubility of neutraceuticals. Nanocapsulation in foods includes the changing of texture, coloring, flavoring and stability in shelf life. Nanocapsules are known to reduce damage that is caused by high loads for components in microelectronics, polymeric coatings and adhesives.

Growing pharmaceutical industry along with the rising demand for nanocapsules are expected to be the major factor driving the global nanocapsules industry. The growing demand from the end user industry is also expected to boost demand for nanocapsules in the near future.

Request For Covid19 Impact Analysis https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=5321

Asia Pacific is expected to be the largest consumer of nanocapsules due to growing pharmaceutical industries in the region. North America and Europe are also expected to boost demand for nanocapsules owing to the growing demand from the end-user industries for various applications.

Read our Case study at :https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Some of the major players profiled for global nanocapsules market include: Capsulation, Sanzyme Ltd, PlasmaChem GmbH, NoCamels, Indian Instruments Manufacturing Company, Encap, Sintef, and Carlina Technologies among others.

More Trending Reports by Transparency Market Research 1.http://www.prnewswire.com/news-releases/increasing-number-of-accidents-and-injuries-to-drive-adoption-of-wound-closure-strips-market-valuation-to-rise-up-to-us446-3-mn-by-2027-end-finds-tmr-301019647.html

2.https://www.biospace.com/article/dna-test-kits-market-increase-in-demand-for-ancestry-testing-to-drive-market/

The rest is here:

Impressive Trends and Future Scope of Nanocapsules Market - StartupNG

Wedding Bells in the Seychelles Islands Read more Skip – eTurboNews | Trends | Travel News

Posted on by

The flames of romance are still ablaze in the enchanting Seychelles Islands, where some 97 couples have walked down the aisle since August 1, 2020, and many others seeking the perfect occasion to tie the knot as tourism restarts in the destination.

Following the reopening of their International Airport, the destination has started to see its wedding market come back to life.

Whilst stranded in the tropical paradise, two couples, according to Registrar for Marriage from the Seychelles Department of Immigration and Civil Status, got married in June. Moreover, with the reopening of the airport, 7 weddings took place on Praslin and 90 destination weddings took place Mah, Silhouette and Enchanted Island since August. Couples from all corners of the world still have their hearts set on Seychelles as their wedding location with many enquiries being made daily.

With romance ever-present in the air, the local authorities and trade are ensuring that no stone is left unturned when it comes to safety. Wedding service specialists and the related service providers of the islands are currently operating under new safety frameworks required under the new normal.

Latest eTN Podcast

The destinations pristine beaches, with its pearly white sand and turquoise waters, have proven to be a very popular location for weddings. Keeping this in mind, procedures have been put into place to ensure lovers can still have an intimate service whilst being kept safe. Minimum contact is to be made between wedding organisers and their clients through measures such as social distancing, use of disposable biodegradable items wherever applicable, no sharing of items and constant use of disinfectant and sanitation processes.

Additionally, the islands also have a reputation for their stunningly lavish hotels, which are also prominent wedding locations. Although room weddings are not permitted, for the time being, the various certified hotels have various open areas, equally as exquisite as the ballrooms, available for couples to choose from. Clients will have to abide by the hotels health and safety regulations, which are reinforced by the Public Health Authority and the Department of Tourism. Similar to beach weddings, measures such as social distancing, sanitisation processes and proper disposal of used items have been put in place to ensure the safety of clients during their ceremony.

The encouraging numbers of weddings in the destination proves that it remains one of the most distinguished wedding destinations, still captivating the hearts of lovers across the globe.

With the world shrouded in chaos and uncertainty, the need to celebrate love and romance has deepened. What location could be ideal to start your lives together than the islands rumoured to be home to the Garden of Eden, where all life began.

More news about Seychelles Islands

#rebuildingtravel

See the rest here:

Wedding Bells in the Seychelles Islands Read more Skip - eTurboNews | Trends | Travel News

President Appoints new Chief Executive Officer of the Seychelles Fishing Authority – Office of the President of the Republic of Seychelles

Posted on by

31 August 2020 | Fisheries

The Office of the President has today announced the appointment of MrNichol John Elizabeth as the new Chief Executive Officer of the Seychelles Fishing Authority, with effect from 1st September 2020, and in accordance with the recommendations of the Board of the SFA.

Mr Elizabeth has a Bachelor's degree in Food Science, and a Master's Degree in Industrial Food Processing. He has since worked in senior positions in the Indian Ocean Tuna Company, Heinz and MWBrands, and was most recently the General Manager of MWBrands in Seychelles.

The President said that it was important for the SFA to be under sound management at a time when the fisheries sector was becoming increasingly vital to the national economy.

The post of CEO of the SFA had been vacant since the departure of Mr Ronny Renaud in 2019. Since February 2020, The Chairman of the SFA, Mr Cyril Bonnelame has been doubling up as the interim CEO pending recruitment formalities.

More:

President Appoints new Chief Executive Officer of the Seychelles Fishing Authority - Office of the President of the Republic of Seychelles

President Faure meets with the Red Cross Society of Seychelles – Office of the President of the Republic of Seychelles

Posted on by

02 September 2020 | State House

President Danny Faure received a delegation from the Red Cross Society of Seychelles at State House this afternoon. The delegation included the President of the Society, Mr Kisnan Tamatave and the Secretary General, Mrs Marie-May Bastienne.

During the meeting the delegation briefed the President on the implementation of the various Red Cross core programmes and projects as well as new activities in line with supporting the country through the COVID-19 pandemic. As a society heavily reliant on volunteers and humanitarian contributions, the Red Cross Society with the support of Government, has over the years managed to implement a number of key projects to support the community, especially during times of emergency and disasters.

President Faure conveyed the country's sincere appreciation to the Red Cross Society of Seychelles for their commitment and continuous support, especially during the ongoing Public Health Emergency where coming together and working in common purpose is key to ensure our community and country remains safe. "Today I would like congratulate the Red Cross Society of Seychelles for your achievements and successful implementation of key community projects despite the challenges. It is this kind of determination and commitment that we encourage other organisations to adopt and our future generations to learn from," said President Faure.

Some of the Societys recent projects include First Aid and Emergency Response training, distribution of a special Hygiene Kit for Students receiving Dedicated Funds in Schools, provision of supplies for temporary shelters in the community, responding with on-site volunteers during the restriction of movement period and collaboration with the Department of Health for various types of support as required.In addition to sharing their accomplishments, the Society also shared ongoing challenges and possible solutions.

The International Federation of Red Cross and Red Crescent Societies (IFRC) of which the Seychelles chapter forms part is the worlds largest humanitarian and development network, with millions of volunteers in 190 member National Societies. The Seychelles Red Cross Society is focused on four core areas: promoting humanitarian values, disaster response, disaster preparedness, and health and community care.

Read more:

President Faure meets with the Red Cross Society of Seychelles - Office of the President of the Republic of Seychelles

Region cautiously reopens its doors – The Southern Times

Posted on by

Southern African countries are cautiously relaxing lockdown regulations and reopening borders after months of lockdown.

For nearly half the year, the only airplanes flying into the region were those mostly carrying returning residents and medical consumables.

With most SADC countries reliant on tourism for revenue, the lockdowns have been keenly felt across economies.

According to a recent SADC report, Sectors that have severely been impacted by COVID-19 include the tourism and leisure, aviation and maritime, automotive, construction and real estate, manufacturing, financial services, education and the oil industry.

South Africas Tourism Business Council says not less than US$4 billion has been lost; and Zimbabwes Tourism Minister Mangaliso Ndlovu puts the countrys losses at around US$1 billion.

Zimbabwe, according to its Environment,

With growing realisation that the new coronavirus is not going away anytime soon, authorities are trying to find the delicate balance between stimulating economic activity while also saving lives.

This has seen several countries in the region making tentative steps to facilitate as much normal economic activity as possible in decidedly abnormal times.

The early bird

Namibias comparatively early move to reopen its airspace is already paying dividends.

Major carriers Qatar Airways, Kenya Airways, Lufthansa and Ethiopian Airlines could all land in Windhoek in coming weeks.

Namibias President Hage Geingob this week said the country had to maximise on its traditional peak tourism period of September to January.

His Environment and Tourism Minister, Pohamba Shifeta, said: This is the beginning of a long process in finding a solution to the financial problems that have been experienced by the important sector.

The Namibian Airports Company is busy making sure that the airports are up to standard. So far we expect to see Qatar, Ethiopian and Lufthansa arriving in the country in the next two weeks after we opened up the ports of entry.

Government has also been involved with several intervention including the unveiling of financial resources to players in the tourism industry to assist them to keep their lights on and also pay salaries to their employees during the difficult period.

The reopening to international travel, Minister Shifeta said, would be done in co-ordination with health, immigration and security authorities.

We are working closely with health officials and when the tourists arrive they will be screened through a process.

One of the key processes is the presentation of COVID-19 free certificates obtained from their home country within 72 hours of travelling.

We will also see to it that the tourists will check into hotels and lodges that have been approved by the government to meet the safety guidelines where they will be retested again in a few days before being allowed to move freely in the country, he said.

In a good year, Namibia receives more than two million visitors while the industry employs tens of thousands of people.

Fortune favours the bold

Tanzania, which has been the least bothered country in the world inasmuch as COVID-19 is concerned, reopened its borders in July.

Tanzania National Parks Assistant Conservation Commissioner (Business Development) Ms Beatrice Kessy said the country had received more than 30,000 visitors since reopening.

Seychelles is another country which has taken the bold move to quickly reopen its borders to tourists.

The Indian Ocean archipelago could not afford to continue blocking out international travelers when 67 percent of GDP comes from tourism.

Recently, Seychelles Public Health Commissioner Jude Gedeon laid out the rules tourists have to abide by.

Visitors are permitted to stay in not more than two approved establishments for the first seven days. When they change accommodation, we must be able to track where they are going to stay next, he said.

While Zimbabwe has not been so bold as to completely fling open its borders, it has been pushing domestic tourism while exploring the possibility of accepting international visitors.

The country has removed quarantine requirements for returning citizens and permanent residents provided they are willing to have a PCR test. If they test negative they can proceed, if otherwise, they are places in isolation.

The country`s biggest tourist attraction, the Victoria Falls Rainforest, was recently reopened, an indication that international tourists may not be far off.

South Africa has remained closed though it too has been on an aggressive domestic tourism drive.

Reporting by Leroy Dzenga in Harare and Tiri Masawi in Windhoek

Visit link:

Region cautiously reopens its doors - The Southern Times

First Mover: As Bitcoin Falls for Second Day, Long-Term Holders Probably Won’t Care – CoinDesk – CoinDesk

Posted on by

Youre readingFirst Mover, CoinDesks daily markets newsletter. Assembled by the CoinDesk Markets Team and edited by Bradley Keoun, First Mover starts your day with the most up-to-date sentiment around crypto markets, which of course never close, putting in context every wild swing in bitcoin and more. We follow the money so you dont have to. You cansubscribe here.

Price Point

Bitcoin was down early Thursday to about $11,250, extending Wednesdays sell-off and falling to its lowest price since early August.[Update: At press time prices had slumped further to around $10,850.]

The cryptocurrency tumbled 4.4% on Wednesday, the most in a month, leading to a heightened level of margin calls and position liquidations. Prices appeared to fall in sync withgold and silver prices, which tumbled as the dollar reboundedfollowing a recent slide.

Failure to hold at the $12,000 level has turned the milksour, the crypto trading firm Diginex wrote in a note to clients. Leveraged longs have been forced to drink it.

Market Moves

With stocks soaring to new records after a decade-long climb, traders in traditional markets are asking how much higher theycango in the midst of a global pandemic, openly discussing whether the market is justpropped up by government stimulus checks and Federal Reserve money injections.

The conversation around bitcoin is very different. The assumption among many digital-asset investors is the cryptocurrencys price will definitely, inevitably go higher, much higher. Its only a matter of time.

Cameron and Tyler Winklevoss, who run the cryptocurrency exchange Gemini, wrote last week thatbitcoin prices could reach $500,000, in an extensive analysis that somehow relates to adatabase of 600,000 asteroids.

Nobody really knows if any of that will pan out, of course. Whats clear is a lot of investors have bought bitcoin because they see it as a deep out-of-the-money option (with no expiration date) on financial Armageddon, severe currency debasement or at the very least an inflation rate well above the Federal Reserves 2% annual target. According toCoinDesk Researchs monthly review published this week, bitcoins price appears to be rising whenever the dollar falls in foreign-exchange markets.

Bitcoin costs $11,200 now, and it might be possible to lose it all, but it also might be worth $500,000 at some point. Thats the general gambit anyway.

Invented just 11 years ago, bitcoin is exceedingly difficult to value partly because it has such a short track record. Similar to gold and many other commodities, the cryptocurrency offers no yield,so bond math wont work. Bitcoin has no earnings or dividend, so stock analysis wont work either.

Philip Bonello, director of research for the money manager Grayscale (owned by CoinDesk parent Digital Currency Group), says his favorite chart for thinking about bitcoins price trajectory might be one showing holders versus speculators. A holder in this case is defined as a bitcoin that has not moved for one to three years, while a speculator coin has moved in the past 90 days.

An increase in holders is considered likely bullish, while an increase in speculators is likely bearish, according to arecent Grayscale report. The idea is that its positive for the market if more investorsappear to be holding the cryptocurrency for the long term, versus those who merely appear to be in it for a quick volatility ride.

Right now, the chart shows holders increasing and speculators decreasing. According to Grayscale, its a similar structure to that of early 2016, just before bitcoin went on a bull run toward its all-time high around $20,000.

Its reassuring, Bonello said Wednesday in a phone interview, that the sentiment of the investor base is growing day by day. The holders appear to have been unfazed by the volatility witnessed in March, when the spread of the coronavirus quickly sent bitcoin prices swooning from above $9,000 to below $5,000. Its probably unlikely that theyre going to sell right now at $11,000, Bonello said.

All of this might mean nothing for the future price of bitcoin. It just shows that a growing number of investors are holding onto their tokens in a bet that the cryptocurrencys price will or even that it might eventually go up. By a lot.

Bitcoin Watch

Token Watch

Ether (ETH):Open positions in Deribits ether options hitrecord high above $500 million.

Bitcoin Cash (BCH):Proposed changes by development team couldreduce rewards for miners, splitting community support.

OKB (OKB):OKEx CEO says foundation burned 3.8 million of its utility tokens, just over 1% of total supply, deepening commitment to deflation at time when central banks around the world are ceaselessly printing money.

Theta Network (THETA):Decentralized streaming network says DeFi could be used to pay content providers who arejust starting out, with few followers.

What's Hot

Analogs

The latest on the economy and traditional finance

Tweet of the Day

See the article here:

First Mover: As Bitcoin Falls for Second Day, Long-Term Holders Probably Won't Care - CoinDesk - CoinDesk

Can You Have Your Bitcoin And Eat It Too? – Forbes

Posted on by

Debating the opportunity costs of earning on your Bitcoin.

Crypto Twitter, like many Twitter-spheres, is as full of self-affirmation and choir preaching as it is of internal holy-wars (not too unlike those described on this post). We can characterize two camps within the crypto/digital asset space. This is a gross oversimplification to be sure, but paints a picture of the space where there are a spectrum of competing ideas.

One group is financial and technically more conservative; this group wants the hardest monetary policy, extremely high levels of computational security, and the ability to self-verify everything. They might see the benefit of more complex functionality, but think this functionality must be built on top of a highly reliable and trustworthy base layer. These folks value minimizing attack vectors, self-auditing, backwards compatibility, and privacy. The Bitcoin Maximalists fit into this group.

The second group is more liberal; they are interested in rapid innovation, maximal flexibility and functionality, and often have higher risk tolerances. While they still value security and decentralization, they are comfortable with a larger set of concepts and designs. There is substantial internal diversity among the members of this group, but many of them envision a future with many successful interconnected projects (rather than a single base layer).

As an example, we recently watched the Bitcoin Maximalists spar with the Ethereum community over issues such as cost to run a full node and auditing a networks total supply in a debate dubbed #supplygate (1, 2).

What if you could benefit from additional functionality without compromising on security?

There is a middle ground forming under the term Bitcoin Centrist. The centrist understands the benefits of both camps ideologies.

Putting Your Crypto to Work

DeFi, or Decentralized Finance, is arguably the hottest subject of 2020 within the crypto space. This new buzz word describes the broad set of protocols which enable decentralized financial product/service applications (acknowledging that there isnt complete consensus on what fits into this category). I aggregated and parsed unique documents mentioning the keyword DeFi using NTerminal in Splunk. We can see an increase in buzz over the course of 2020:

Sentiment Analysis for the Keyword "DeFi"

People are interested in DeFi both for its potential in Reinventing Global Finance, and as a way to make massive investment returns. DeFi applications include systems such as automated market making, derivatives, and lending. Yield Farming is the process of utilizing DeFi protocols to generate yield on ones digital assets.

YFI (the token for Yearn Finance), for example went from trading around $4,000 at the start of the month to a price of over $36,000, surpassing $1 billion in marketcap:

YFI-USD Reported Price & Volume on FTX and NLP mentions by Sentiment

These protocols, of course, are far from being risk-free, and this market activity does not appear to be sustainable. In some ways the DeFi craze mirrors what we saw in 2017 with the ICO boom, when projects were pulling millions of dollars before anyone had time to find the associated white paper.

Yam Finance Marketcap Aug 11-17

Yam Finance (with the symbol YAM) was an unaudited project started in just 10 days (start to finish according to them) which was launched on Aug 11th. According to Coingecko, it hit a market cap of almost $60 million on Aug 13th. Then, a bug was discovered which locked up ~ $750,000 in Curve y tokens and the price immediately plummeted.

But what about tokenized Bitcoin?

The amount of Bitcoin locked on Ethereum has exploded over the last month. The USD value locked in WBTC and RenBTC, the two leading methods of locking your BTC into Ethereum transactions have outpaced the production of Bitcoins earned by miners:

Total Value Locked (USD) in WBTC

Total Value Locked (USD) in RenVM

Each of these methods carry a unique set of risks. WBTC is an ERC20 token backed 1:1 with BTC which involves a custodian, and the KYC that comes with it.

The renBTC token uses the Ren Virtual Machine to mint BTC to an Ethereum smart contract. This method avoids the counterparty risk, but could be void of any way of retrieving trapped funds.

In addition to counter party and/or smart contract risks, users must pay outrageously high gas prices on their transactions (which could fail), navigate the various platforms which enable the minting of these tokens, and make sure they avoid scams and user errors along the way.

Conceptually, locking your assets into smart contracts which allow you to put your money to work is great. If it is possible to generate income without compromising the financial sovereignty offered by permission-less and censorship-resistant money like Bitcoin, it would benefit both the Maximalists and Yield Farmers alike.

Today, however, Bitcoin (as well as Yams and Sushi) still abides by the same rules as cake. While there are now various ways of putting your digital money to work, there are important risks and trade offs associated with them. I expect the Bitcoin Centrist camp to grow as these trade offs are reconciled by developers and users.

See original here:

Can You Have Your Bitcoin And Eat It Too? - Forbes

If Bitcoin Crashes Below $10,000 Its All OverHeres Why – Forbes

Posted on by

Bitcoin has declined sharply this week, losing over 5% in under 24 hours and causing traders to nervously eye the psychological $10,000 per bitcoin level.

The bitcoin price lost $1,000 in a matter of hours, falling under $11,000 per bitcoin on Thursday morning with the U.S. stock market posting its biggest sell-off since June by the close of play as stocks retreated from all-time highs, led lower by tech giants.

Bitcoin and cryptocurrency market watchers, who have enjoyed a prolonged bull market since the March coronavirus crash, are now focused on the $10,000 line, with a bitcoin futures trading gap set in late July still open just below it.

The bitcoin price lost almost $1,000 per bitcoin in under 24 hours, sparking fears among bitcoin and ... [+] cryptocurrency traders of a wider sell-off.

Bitcoin's 2020 bull market, which has seen the bitcoin price surge from around $4,000 to $12,000, could be brought to an abrupt end if the price moves lower than $10,000 per bitcoin.

"Moving forward, it is important to keep an eye on the last zone of defense between $10,000 and $10,500," Joe DiPasquale, the chief executive of San Francisco-based bitcoin and crypto hedge fund BitBull Capital, said via email. "As long as this range is respected, bitcoin is unlikely to see a prolonged bearish spell."

The bitcoin price fell as low as $10,455 per bitcoin on the Luxembourg-based Bitstamp exchange on Thursday before somewhat rebounding.

The open trading gap, set on July 27, saw bitcoin futures on the Chicago Mercantile Exchange (CME) open higher after the weekend close, something some analysts think causes a disconnect with the underlying market and appears to have set bitcoin on its path to recent highs of around $12,000. Technical analysis shows that 90% of such trading gaps are eventually closed, with the price sooner-or-later retracing back to the gap.

Elsewhere, bitcoin and cryptocurrency exchange data suggests there could still be "sell pressure to work through," according to Philip Gradwell, chief economist at blockchain intelligence firm Chainalysis.

"Bitcoin inflows to exchanges were 92,000 yesterday, highest in 37 days, as people rushed to sell at near $12,000 prices of September 1," Gradwell said via Twitter. "Trade intensity, how many times the inflowing bitcoin was traded, is low, suggesting there were not many buyers to match the sellers."

Meanwhile, bitcoin miners, those who secure the cryptocurrency's network in return for bitcoin rewards, "are moving unusually large amounts of bitcoin," according to analysts at data provider CryptoQuant, suggesting miners are looking to cash out their bitcoin rewards.

"The big level that everyone is watching is $10,000," Mati Greenspan, the founder of Quantum Economics, wrote in his popular daily newsletter, pointing to a U.S. dollar comeback as the reason for the recent move lower.

"The crypto market has broken a few psychological levels. When we broke above that level in late July, it was with such force that we never really got to test it as support. Well, this may just be our chance," Greenspan wrote, adding, "if things get really bad we may just get another chance to buy bitcoin below $10,000."

The bitcoin price has lost almost 6% over the last 24-hour trading period, with the bitcoin market ... [+] capitalization falling under $200 billion.

However, many in the bitcoin and cryptocurrency community remain upbeat despite the recent bitcoin price fall.

"$10,000 is the new $1,000," Charles Hayter, chief executive of bitcoin and cryptocurrency analytics platform CryptoCompare, said via email, adding: "2020 has seen leaps and bounds in terms of infrastructure, regulation and resilience across the ecosystem as it has evolved over the last three years."

The current bitcoin market is "similar to the first half of 2017," according to Hayter, who thinks "the perpetual dilution of fiat currencies is being challenged by bitcoins hard code cap" of 21 million bitcoin tokens.

Bitcoin, along with the wider cryptocurrency market and global stock markets, has been boosted this year by massive stimulus measures and unprecedented money printing that's carried out by the world's central banks, led by the U.S. Federal Reserve, in order to offset the economic damage wrought by the coronavirus pandemic.

"For most of 2020, short-term bitcoin price moves have been highly correlated to U.S. stocks," Cory Klippsten, the chief executive of bitcoin buying app Swan Bitcoin, said via Telegram, adding he expects "any dips under $10,000 to be bought up voraciously."

"Bitcoin has proven to be uncorrelated over the longer term. At a minimum it is a hedge against fiat inflation, but it also functions as a call option on a new global monetary system."

View original post here:

If Bitcoin Crashes Below $10,000 Its All OverHeres Why - Forbes

A Radical New Crypto Just Blew Past The Bitcoin Price All-Time HighUp A Shocking 3,500% In Just One Month – Forbes

Posted on by

Bitcoin and cryptocurrency markets have been dominated by decentralized finance, often shortened to DiFi, over recent months.

The bitcoin price, up around 40% since the beginning of 2020, has been left in the dust by the gains made some DeFi project tokensincluding yearn.finance (YFI) that's up a staggering 3,500% in just a little over a month and has surged past bitcoin's late-2017 $20,000 all-time high.

Bitcoin remains the biggest cryptocurrency by total value with a market capitalization of over $200 ... [+] billion, however, individual yearn tokens are now worth far more than single bitcoins.

The price of yearn.finance tokens have soared from under $1,000 per YFI since it was created in mid-July to over $30,000 this weekend, passing the bitcoin price on Friday. The yearn.finance price came close to $40,000 on some bitcoin and cryptocurrency exchanges before falling back.

YFI is the governance token of DeFi protocol yEarn, designed to aggregate yields from other lending protocols. DeFi is the idea cryptocurrency technology can be used to recreate traditional financial instruments such as loans and insurance.

YFI holders can use their tokens to vote on proposals for network upgrades and it can be earned by putting cash into yEarn, a practice known as yield farming.

"The yearn.finance coin has become the altcoin star recently," Alex Kuptsikevich, FxPro senior financial analyst, said via email.

"In a month it has shown twentyfold growth, living proof that 'unicorns' still exist, at least in crypto. The rapid growth of the coin also reflects the popularity of the decentralized financial sector. The creators of the project decided to follow the bitcoin path, limiting the issue of only 30,000 YFI coins. Such limited supply spurs rapid price growth."

This price growth was not something planned by the YFI creator, however. Yearn.finance tokens were described as "completely valueless 0 supply token," by its creator Andre Cronje.

The yearn price has jumped by 26% in just the last 24 hours, adding to massive gains through August ... [+] and leaving the bitcoin price in the dust.

"We reiterate, it has 0 financial value," Cronje wrote in a Medium post last month outlining the project.

"There is no pre-mine, there is no sale, no you cannot buy it, no, it wont be on uniswap, no, there wont be an auction. We dont have any of it."

But this warning hasn't stopped some of the biggest personalities in bitcoin and crypto from making outlandish predictions about the YFI price.

"One YFI [equals] $100,000," Arthur Hayes, the chief executive of the Seychelles-based bitcoin and cryptocurrency exchange BitMEX, said via Twitter, forecasting the yearn.finance price would continue to climb and hit $100,000.

Go here to read the rest:

A Radical New Crypto Just Blew Past The Bitcoin Price All-Time HighUp A Shocking 3,500% In Just One Month - Forbes

Private Capital And Institutions Are Piling Into Bitcoin And Other Digital Assets But You Need To Know Where To Look – Forbes

Posted on by

Many in the crypto and digital assets markets have been claiming that institutions are moving into this space and are now banging down the digital door to get access to this asset class. They may finally be onto something.

By many measures, the market for digital assets is growing at a pace that appears primed for broader adoption by more sophisticated players in the markets like private capital, pensions funds, endowments, traditional hedge funds, and banks.

The crypto derivatives market is a leading example of this. It has been growing faster than the spot market over the past three years and is now estimated to be 40% of the top global exchange volume according to CryptoCompare in their July Exchange Review Report.

"In the last two years we have seen traditional pension funds likeFairfax Countys Virginias Police Officers Retirement System, traditional banks like JP Morgan, Signature Bank, and multiple billion dollar family offices across the country holding and investing in Bitcoin and other crypto currencies," says Kavita Gupta, visiting scholar at Stanford University.

Institutions often cite regulatory uncertainty as one of the main reasons for not allocating to crypto and digital assets, and they have a point. Most tokens and coins fall under a legal grey area that has yet to be clarified by most major securities authorities. Derivatives are a different breed.

The US Commodities Futures Trading Commission (CFTC) is considered one of the planets toughest regulators, and they have approved several crypto futures contracts for trading like CME's Bitcoin Options, NYSEs Bakkt, and LedgerX. This approval comes despite their refusal to approve a Bitcoin ETF as they judge the spot market as unreliable and manipulated to a much higher degree than most people realize.

The widespread availability of these derivatives has led to private capital and institutions allocating to them, seemingly setting or matching new records with each passing month. Open interest in Bitcoin contracts hit an all time high of $2.1 billion on July 31st and then nearly matched that mark with the August expiry that passed just last week.

In the U.S. alone, anyone with a TD Ameritrade or Robinhood account can invest in crypto options just as easily as buying a share of Apple AAPL or Tesla TSLA , and this has likely contributed to the explosive growth seen in options trading volumes this year. The rumour in the professional COVID-19 work at home community in the global financial services sector is that the vast numbers of new homeworkers has contributed to the retail volume of derivative trading.

It helps to have traditional heavyweights like the CME and NYSE behind these contracts, and while growth started slowly and intermittently, it is now moving at a steady pace. According to a recent research report by Tokeninsight, derivatives trading volume is rising steeply, up 100 percent from the same period one year ago as spot volumes have seen a drop, down 18% in Q2 but still have yet to pass spot trading volumes.

There are also venues like Huobi, Bitmex, and Deribit, and investors are flocking to them not only because they are seen as safer by some, but also because of the flexibility and creativity found in derivatives markets.

Denis Vinokourov, head of research for digital assets prime broker Bequant, recently commented in CoinTelegraph, Options are a very efficient way to hedge exposure to the underlying product, be that Bitcoin or Ethereum spot or even futures/perpetuals. In addition, it is easier to structure products that would offer yield, and it is this that has been particularly appealing to market participants, especially in the wake of sideways market price action.

Crypto assets are growing and the markets are maturing at a remarkably fast pace given their relative infancy. Bitcoin is increasingly gaining mainstream awareness as public companies and central bankers discuss it with stablecoins, central bank digital currencies (CBDCs), and the Digital Yuan, increasingly as a prolonged economic downturn caused by the COVID-19 pandemic looks increasingly likely.

Last month a publicly traded company MicroStrategy MSTR became one of the single biggest individual holders of Bitcoin when it bought about $250 million worth of BTC because it is a reasonable hedge against inflation that is superior to cash.

This led to a short-lived rally, but this was less important than the initial indications that larger firms are now starting to seek out alternatives to the US Dollar, and in this case, one was confident enough in Bitcoin to convert nearly all of its cash reserves into the cryptocurrency.

This phenomenon is global with Asian companies not to be outdone. This weeks announcement by the Singapore Exchange about its entry into digital asset products is a telling barometer for institutional interests globally.

This is no surprise as Asian institutions make up the lions share of trading volumes in spot, futures and derivative products, said James Harris, at CryptoCompare, expect more to come, especially in the Asia Pacific region, and soon.

A number of larger exchanges around the world are also long on digital assets including the London Stock Exchange Group, Nasdaq and the Swiss Stock Exchange (SIX-Group) who is building a full digital exchange, SDX, in partnership with R3 and are also exploring platforming the Swiss National Banks (SNB) digital currency.

Spot markets have since rallied sporadically but are struggling to stay above $12,000, trading mostly in a narrow range between $11,300 and $11,800 while DeFi coins like YFI have surged in unprecedented parabolic runs that have made instant millionaires overnight only to see some of those lose all their gains almost as quickly, as in the case of YAM.

A likely contributor to this tentative price action is the weariness traders have that another storm cloud is often on the horizon. Ethereum Classic (ETC) had three 51 percent attacks last month alone. This week saw South Korean regulators raiding the offices of BitThumb, one of the worlds largest crypto exchanges, over allegations of fraud related to an IEO and a potential buyout offer.

Bitcoin fell nearly five percent and other digital assets were dragged down with it. In an orderly market, circuit breakers would be triggered. Trading would be suspended, and investors would have been protected.

These measures dont exist in digital asset spot markets and flash crashes lead investors of all types to incur losses they otherwise wouldnt in traditional, fully regulated markets. Until the risk of this unpredictability can be better managed, it might be a while before more sophisticated investors look too far beyond traditional derivatives markets which are, after all, notionally the largest market in the world.

View post:

Private Capital And Institutions Are Piling Into Bitcoin And Other Digital Assets But You Need To Know Where To Look - Forbes

First Mover: Buying Bitcoin’s Dip, Betting Against Tether and Weighing the Jobs Report – CoinDesk – CoinDesk

Posted on by

Youre readingFirst Mover, CoinDesks daily markets newsletter. Assembled by the CoinDesk Markets Team and edited by Bradley Keoun, First Mover starts your day with the most up-to-date sentiment around crypto markets, which of course never close, putting in context every wild swing in bitcoin and more. We follow the money so you dont have to. You cansubscribe here.

HOLIDAY NOTICE:First Mover will publish next on Tuesday, Sept. 8. Happy Labor Day to our U.S. readers.

Price Point

Bitcoin (BTC) was up in early trading to $10,500, rebounding after Thursdays 11% tumble, the biggest single-day declinesince March.

The sell-off,which took prices as low asabout $10,000, coincided with a rout in U.S. stocks, rekindlinglong-simmering discussionsover whether the largest cryptocurrency was a safe haven like gold or merely another risky asset. Prices for ether (ETH), the native token of the Ethereum blockchain, slid 13%, potentially a sign of anunwind of the recent fervor in decentralized finance, or DeFi. U.S. 10-year Treasury yields fell and the dollar gained in foreign-exchange markets, indicating a flight to safety by traditional investors.

Joe DiPasquale, CEO of the cryptocurrency-focused hedge fund BitBull Capital,told First Mover in an email that $10,000 still stands as a strong support and has absorbed selling pressure fairly well in the last two instances.John Kramer, a trader at crypto over-the-counter firm GSR, told CoinDesks Daniel Cawrey that many investors will see this as an opportunity tobuy the dip.

Market Moves

Afteryears of debatingwhether tether (USDT) is fully backed 1-for-1 with U.S. dollars, thestablecoins critics and defenders alike can now put their money where their mouths are.

Opium, a derivatives exchange, has introduced credit default swaps (CDS) for USDT. The product, launched Thursday, insures the buyer in the event of default by Tether, the issuer of the worlds largest stablecoin andfifth-largest cryptocurrency overall.

As Opiums blog points out, USDT is the lifeblood of theborderless cryptocurrency marketplace. The oldest stablecoin, USDT remains the largest such cryptocurrency by market cap and a top-five coin overall with$13.8 billionin issuance.Traders often use it to move money in and out of exchanges quickly to take advantage of arbitrage opportunities.

You can use it to protect yourself against (or speculate on) a systemic failure of the most widely used stablecoin in crypto, Opium said of the new CDS contract, in a blog post to be published Thursday.

There are nagging questions about the issuers creditworthiness. The firm behind USDT isunder investigationby the New York Attorney Generals office for alleged misappropriation of funds, andTetherrevealedin April 2019 that only 74% of USDT was backed by cash and cash equivalents.

Paolo Ardoino, chief technology officer at Tether, said through a spokesman: Tether is solvent. Therefore, this solution is not really interesting to us or our community.

The solution might be interesting to traders who just want a little extra assurance.

Bitcoin Watch

Bitcoins options market has flipped bearish with the cryptocurrency registering its first double-digit decline in six months on Wednesday. Prices fell to a low of $10,006 before recovering to $10,500.

Token Watch

Ether (ETH):Vitalik Buterin, co-founder of Ethereum, released an improvement proposal to address soaring transaction fee ratesas network congestion rises.

Bitcoin (BTC):Supercycle thesis from Stack Funds predictsbreach of $14K in next 100 days.

Tether (USDT), USD Coin (USDC):Stablecoins are theclosest thing to digital cash that exists today, Castle Islands Nik Carter writes for CoinDesk.

Chainlink (LINK), Tezos (XTZ):BitMEX plans futures on LINK and XTZ, thefirst new coins to appear on the exchange in over two years.

Gnosis (GNO):Investment firm Arca calls for tender offer of prediction markets tokens asmarket value trades at 0.3% of projects treasury balance, the Block reported.

CoinDesk Researchs latest Monthly Review features 15 charts that highlight bitcoins performance relative to macro assets, its relationship to the dollar and other fiat currencies, and Ethereums growing congestion problem. Download the report.

What's Hot

Analogs

The latest on the economy and traditional finance

Tweet of the Day

Originally posted here:

First Mover: Buying Bitcoin's Dip, Betting Against Tether and Weighing the Jobs Report - CoinDesk - CoinDesk